Okuvision GmbH

Okuvision GmbH is a German medical device company based in Kusterdingen, Baden-Württemberg. Founded in 2007, it operates independently and specializes in ocular electrical stimulation technology. The company focuses on developing innovative therapies for retinal diseases, particularly retinitis pigmentosa (RP). Okuvision manufactures the CE-marked OkuStim® therapy system, a non-invasive device designed to delay the progression of retinitis pigmentosa. This system promotes cell regeneration in the retina through transcorneal electrical stimulation (TES). It includes a wearable frame, a handheld stimulation controller, and a battery pack, allowing patients to self-administer treatment at home or receive it in a clinical setting. The therapy is generally painless and aims to preserve vision and slow visual field loss for patients in the early to intermediate stages of RP. With a portfolio of 18 patents and contributions to scientific literature, Okuvision is dedicated to advancing treatment options for retinal diseases.

• Employees9
• Founded2007